Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/s41577-020-00472-0 http://scihub22266oqcxt.onion/10.1038/s41577-020-00472-0 33087904!7576971!33087904     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Nat+Rev+Immunol 2020 ; 20 (12): 715-716 Nephropedia Template TP {{tp|p=33087904|t=2020. Immunological considerations for SARS-CoV-2 human challenge studies |pdf=|usr=}}{{33087904}} gab.com Text Immunological considerations for SARS-CoV-2 human challenge studies JO: Nat Rev Immunol http://www.kidney.de/pget.php?&tw=1&pmid=33087904 #FOAvip The ethics and practicalities of controlled human infection with SARS-CoV-2 have been widely discussed. Potential risks are clear. The case in favour hinges upon whether these risks can be mitigated to an acceptable, very low, level and whether the studies will provide substantial benefits that could not readily be obtained by other means. Here, we discuss the immunological considerations relating to each side of this balance. Twit Text FOAVip Immunological considerations for SARS-CoV-2 human challenge studies ????Nat Rev Immunol http://www.kidney.de/pget.php?&tw=1&pmid=33087904 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33087904 #FOAvip English Wikipedia <ref>{{Cite pmid|33087904}}</ref> Immunological considerations for SARS-CoV-2 human challenge studies #MMPMID33087904 Douglas AD; Hill AVS Nat Rev Immunol 2020[Dec]; 20 (12): 715-716 PMID33087904show ga The ethics and practicalities of controlled human infection with SARS-CoV-2 have been widely discussed. Potential risks are clear. The case in favour hinges upon whether these risks can be mitigated to an acceptable, very low, level and whether the studies will provide substantial benefits that could not readily be obtained by other means. Here, we discuss the immunological considerations relating to each side of this balance. |*Healthy Volunteers[MESH] |COVID-19 Vaccines/immunology[MESH] |COVID-19/*immunology[MESH] |Humans[MESH] |Models, Biological[MESH] |Research Design[MESH]Immunological considerations for SARS-CoV-2 human challenge studies (epmc).pdf DeepDyve Pubget Overpricing